The Access to COVID-19 Tools (ACT) Accelerator

The Access to COVID-19 Tools (ACT) Accelerator

WHO/P. Phutpheng
© Credits

Since April 2020, the ACT-Accelerator partnership, launched by WHO and partners, has supported the fastest, most coordinated, and successful global effort in history to develop tools to fight a disease. With significant advances in research and development by academia, private sector and government initiatives, the ACT-Accelerator is on the cusp of securing a way to end the acute phase of the pandemic by deploying the tests, treatments and vaccines the world needs.

This document was developed under the leadership and direction of the ACT-A Pillar Co-Conveners and Agency Leads in consultation with the broader ACT-A...

Resources

All →

The Vaccine Manufacturing Working Group (VMWG) was established by the Access to COVID-19 Tools Accelerators (ACT-Accelerator) Facilitation Council in May...

The ACT-Accelerator Commitment Tracker provides transparent reporting on funding commitments made against ACT-Accelerator Pillar budgets. Urgent action...

Note: Report updated on 15 Sept 2021 with removal of reference to the average price of antigen RDTs on page 3, removal of reference to price reductions...

This 2020-2021 Impact Report looks back at the challenges and progress of the ACT-Accelerator over the last year. It highlights the accelerated actions...

The Facilitation Council provides high-level political leadership and enabling advice on global advocacy and resource mobilization to facilitate the work of the COVID-19 Tools Accelerator (ACT-A), its global collaborative framework, and its partnerships to ensure the realization of the ACT-A vision: the rapid development, scale-up and equitable distribution of COVID-19 vaccines, therapeutics and diagnostics, underpinned by the strengthening of health systems.

Formally launched on 10 September 2020, the Council is currently co-chaired by Norway and South Africa.

Screenshot 2021-06-08 at 16.10.57